High Flow Oxygen Therapy Devices Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: High Flow Oxygen Therapy Devices Market covers analysis By Product (High Flow Nasal Cannulas, High Flow Oxygen Masks); Application (Breathing Circuits, Pneumonia); End Use (Heated Humidifiers and Accessories, Home Healthcare), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Oct 2023

  • Report Code : TIPRE00029974
  • Category : Medical Device
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy



High flow oxygen treatment is a non-invasive form of respiratory support provided to patient with warmed and humidified air with enhanced oxygen. Patients with spontaneous breathing require greater oxygen flow rates as high flow oxygen therapy can help patients with acute hypoxemic respiratory failure breathe by supporting their respiratory system and delaying intubation. Patients recover more quickly after extubation due to improvements in oxygenation, respiratory rate, dyspnea, and patient comfort which results in better outcomes and shorter stays in the ICU. This oxygen therapy is also less expensive because it can be used in several medical departments without ventilator.

Furthermore, the nasal cannula used in High flow oxygen therapy is more pleasant for the patient and may be worn continuously for long periods. Controlled heating and humidification are applied to the gas stream, this avoids mucosal dryness and its side effects. It just needs a heating/humidification system, a compressed air source, and an oxygen source.

A customized binasal High flow nasal cannula (HFNC) and a heated inspiratory breathing circuit are used to administer high flow oxygen treatment. It is used to apply heated, humidified, and oxygen-blend air at high flow rates, usually adjusted between 30 and 50 l/min. In addition to producing positive end-expiratory pressure, this high flow can deliver more consistent inspiratory oxygen concentrations than traditional oxygen therapy. Additionally, HFNC devices use oxygen-enriched gas to flush away expired CO2 from the inspiratory dead space in the airways. Patients with mild to severe hypoxemic respiratory failure can benefit from High flow oxygen therapy. As a preventive measure against post-extubation respiratory failure, high flow cannulas have shown to be effective and consistently be better tolerated then non-invasive ventilation (NIV) therapy.

The "Global high flow oxygen therapy devices market analysis to 2030" is a specialized and in-depth study of the medical device industry with a special focus on global market trend analysis. The report aims to provide an overview of the high flow oxygen therapy devices market with detailed market segmentation by product type, application, end use, and geography. The report provides key statistics on the market status of the leading high flow oxygen therapy devices market players and offers key trends and opportunities in the market.

The high flow oxygen therapy devices market is segmented based on product type, application, end use, and region. Based on product type, the global high flow oxygen therapy devices market is differentiated into high flow nasal cannulas, high flow oxygen masks, breathing circuits, and heated humidifiers & accessories. The high flow oxygen therapy devices market is bifurcated by application into pneumonia and acute respiratory failure. Based on end use, the high flow oxygen therapy devices market is bifurcated into home healthcare and non-home healthcare.

The COVID-19 outbreak's increased incidence of acute respiratory failures (ARF), the risk of community infection, the rising demand for high flow nasal cannulas, and developments in high flow oxygen therapy devices are some of the major drivers of the market. Global public health problems, such as pneumonia, asthma, interstitial lung disease, and acute respiratory failure (ARF), place a high socioeconomic cost on people and societies. The main risk factor for ARF is COVID-19 and patients with pneumonia and other COVID-19 symptoms are more likely to develop ARFs. The demand for high flow oxygen therapy equipment is fueled by the world's ageing population and greater exposure to risk factors, making ARF and pneumonia more prevalent health issues. According to estimates from the Child Health Epidemiology Reference Group of the World Health Organisation (WHO), there were 1,400 cases of pneumonia per 100,000 children in 2020. Of these, 13% were severe and required immediate hospitalization.

Furthermore, increasing funding for R&D activities to launch novel products & solutions and healthcare recognition & recommendation of high flow nasal cannula oxygen therapy will continue creating growth opportunities for manufacturers and users through the assessment period. For instance, In January 2020, Royal Papworth Hospital granted 1.5 million (£1.4M) to fund nasal oxygen study. Thus, increasing funding will drive the high flow oxygen therapy devices market growth.

Due to the presence of major players, the high prevalence of respiratory disorders, and the developed healthcare infrastructure, North America is anticipated to dominate the global high flow oxygen therapy devices market over the forecast period. The rising prevalence of respiratory illnesses is one of the major factor promoting the market growth in the region. For instance, according to estimates provided by the Asthma and Allergy Foundation of America (AAFA), over 25 million Americans, or roughly 1 in 13 persons, were estimated to have asthma in 2022 and it is also estimated that 5.1 million American children under 18 have asthma. Additionally, as per the same source, women (9.8%) had a higher prevalence rate of asthma as compared to men (6.1%).

Furthermore, the high flow oxygen therapy devices market players are implementing various strategies, including alliances, partnerships, and product launches, which favors the market growth of high flow nasal cannulas. For instance, In February 2021, Masimo launched softFlow, its innovative pulmonary care therapy which offers nasal high flow warmed and humidified respiratory gases to spontaneously breathing patients. The technology offers adult patients High flow respiratory support via a soft nasal cannula by generating a consistently high flow of warm, humidified oxygen mixture.

World Geography

Have a question?


will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

The report covers key high flow oxygen therapy devices market developments, such as organic and inorganic growth strategies. Various companies such as Draegerwerk AG & Co. KGaA, Teleflex Medical GmBH, Philips Respironics, Vapotherm, Inc., ResMed, Vyaire Medical, Inc., Fisher & Paykel Corporation Ltd., Armstrong Medical, Flexicare Medical, Hamilton Medical Inc. and among others are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The key players from the high flow oxygen therapy devices market are anticipated to have lucrative growth opportunities with the rising demand for oxygen therapy products in the global market.

Key Developments in the Global High flow oxygen therapy devices market

  • In August 2021, ResMed launched AirSense 11 in the United States, its a next-generation PAP (positive airway pressure) device particularly used for therapy to treat and manage obstructive sleep apnea.
  • In August 2020, Nocca Robotics Pvt Ltd launched a high flow oxygen therapy device, Noccarc H210. This deviced is used to treat COVID-19 patients and is simple to use and comfortable. High flow oxygen therapy significantly reduces the chances of intubation.
  • In June 2020, Armstrong Medical launched second generation FD140i, an enhanced dual therapy flow driver with an easier transition from CPAP to HFOT.

The report also includes key companies' profiles, their SWOT analysis, and high flow oxygen therapy devices market size and strategies. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information for the last three years, and key development in the past five years.

The Insight Partner's dedicated research and analysis team comprises experienced professionals with advanced statistical expertise and offers various customization options in the current study.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports